Compositions and methods of treating retinal disease

Details Compositions and methods of treating retinal disease Compositions and methods of treating retinal disease

2011-07-05

2011-07-05

Fetterolf, Brandon J (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C546S152000

Reexamination Certificate

active

07973025

ABSTRACT:
Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.

REFERENCES:
patent: 2086186 (1937-07-01), Messer
patent: 6191127 (2001-02-01), Holscher et al.
patent: 2007/0129404 (2007-06-01), Hagihara et al.
patent: WO 2004/082622 (2004-09-01), None
patent: WO 2005/079774 (2005-09-01), None
Westphal et al ‘Reactions with pyridinium pyruvic acid esters’ Pharmazie, 31(11), p. 770-773, 1976.
English Traslation of: Westphal et al ‘Reactions with pyridinium pyruvic acid esters’ Pharmazie, 31(11), p. 770-773, 1976.
Acland et al.Nat. Gen., 28:92-95 (2001).
Bernstein et al.Vision Res. , 25(6):741-748 (1985).
Bernstein et al.Proc. Natl. Acad. Sci. USA, 83:1632-1635 (1986).
Bernstein et al.Biochem., 25:3370-3377 (1986).
Bernstein et al.Am. J. Ophthalmol., 124(6):843-844 (1997).
Bucciantini et al.Nature, 416:507-511 (2002).
Chapple et al.Trends Mol. Med., 7(9):414-421 (2001).
Dowling J.E.,J. Gen. Physiol., download from www.jgp.org on Aug. 23, 2006, pp. 1287-1301.
Drysdale et al.Proc. Natl. Acad. Sci. USA, 97(19):10483-10488 (2000).
Fowler et al.J. Photochem. Photobiol. B. Biol., 8:183-188 (1991).
Hubbard R.,J. Am. Chem. Soc., 78:4662-4667 (1956).
Karan et al.Proc. Natl. Acad. Sci. USA, 102(11):4164-4169 (2005).
Li et al.Proc. Natl. Acad. Sci. USA, 95:11933-11938 (1998).
Noorwez et al.J. Biol. Chem., 278(16):14442-14450 (2003).
Organisciak et al.Invest. Ophthalmol. Vis. Sci., 44:486-492 (2003).
Parish et al.Proc. Natl. Acad. Sci. USA, 95:14609-14613 (1998).
Radu et al.Proc. Natl. Acad. Sci. USA, 100(8):4742-4747 (2003).
Rapp et al.Vision Res., 22:1097-1103 (1982).
Sherman et al.Neuron, 29:15-32 (2001).
Sieving et al.Proc. Natl. Acad. Sci. USA, 98(4):1835-1840 (2001).
Weng et al.Cell, 98:13-23 (1999).
Yarnell, A.,C&EN, http://www.cen-online.org., pp. 22-23 (2004).
Conover et al., “Thiazole analogs of pyridoxine”,J. Am. Chem. Soc., 72:110:5221-5225 (1950).
Hurd et al., “Reaction of propiolactone with aniline derivatives”,J. Am. Chem. Soc., 74:5889-5891 (1952).
Nerurkar et al., “β-arylglutaconic acids. II. Imides of certain β-arylglutaconic and glutaric acids”,J. Org. Chem., 24:2055-2056 (1959).
Snell et al., “Novel structure having antagonist actions at both the glycine site of the N-Methyl-D-Aspartate receptor and neuronal voltage-sensitive sodium channels: biochemical, electrophysiological, and behavioral characterization”,J. Pharmacol. Exp. Therapeutics, 292(1):215-227 (2000).
Wang et al., “A facile one-pot synthesis of 2-substituted-3-aminoquinolines: preparation of benzo[b]naphthyridine-3-carbonitriles”,Tetrahedron, 60(13):2937-2942 (2004).
International Search Report for PCT/US2006/020320, mailed Sep. 26, 2006.
Vlaskina et al., “Novel Synthesis of Substituted Benzimidazoles by Reduction of Esters of 4-Alkylamino-3,5-Dinitrobenzoic Acids by Tin Chloride”,Chemistry of Heterocyclic Compounds, 40(4), 523-524 (2004).

Affiliated with

Also associated with

Rating

Compositions and methods of treating retinal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods of treating retinal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of treating retinal disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2639659